Cocrystal Pharma (COCP) Depreciation & Amortization (CF) (2010 - 2026)
Cocrystal Pharma (COCP) reported Depreciation & Amortization (CF) of $12000.0 for Q1 2026, down 52.0% on a YoY basis from $25000.0 in Q1 2025, and down 7.69% sequentially from $13000.0 in Q4 2025.
Cocrystal Pharma (COCP) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $12000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 52.0% year-over-year to $12000.0; the trailing twelve-month figure through Mar 2026 stood at $59000.0 (down 49.14% YoY), and the FY2025 full-year result was $72000.0, down 42.86% from the prior year.
- Depreciation & Amortization (CF) retreated to $12000.0 in Q1 2026, from $13000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $53000.0 in Q3 2023 to a low of $12000.0 in Q1 2026.
- A 5-year average of $34352.9 and a median of $35000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) increased 12.77% in 2023 and plunged 56.67% in 2025, its largest moves.
- Tracing COCP's Depreciation & Amortization (CF) over 5 years: stood at $48000.0 in 2022, then slipped by 16.67% to $40000.0 in 2023, then slipped by 30.0% to $28000.0 in 2024, then sank by 53.57% to $13000.0 in 2025, then fell by 7.69% to $12000.0 in 2026.
- Business Quant data shows COCP's Depreciation & Amortization (CF) at $12000.0 in Q1 2026, $13000.0 in Q4 2025, and $13000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 41.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.20 Mn |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | 12,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Mar 31, 2024 | 35,000.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Dec 31, 2023 | 40,000.00 |